Cargando…

Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer

INTRODUCTION: Retinoic acid-induced 2 (RAI2) was initially related to cell differentiation and induced by retinoic acid. RAI2 has been identified as an emerging tumor suppressor in breast cancer and colorectal cancer. METHODS: In this study, we performed systematic analyses of RAI2 in breast cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Ying, Li, Shiyu, Gong, Juejun, Zheng, Kun, Xie, Ya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090471/ https://www.ncbi.nlm.nih.gov/pubmed/37064084 http://dx.doi.org/10.3389/fonc.2023.1134149

Ejemplares similares

An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy
por: Zhao, Hao, et al.
Publicado: (2022)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer
por: Yu, Jing, et al.
Publicado: (2021)

Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer
por: Zhang, Weitao, et al.
Publicado: (2022)

Comprehensive analysis of alfa defensin expression and prognosis in human colorectal cancer
por: Zhao, Xinliang, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Comprehensive Analysis of Regulatory Networks of m6A Regulators and Reveals Prognosis Biomarkers in Sarcoma
por: Pang, Boran, et al.
Publicado: (2022)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma
por: Pan, Ya-Qiang, et al.
Publicado: (2022)

Comprehensive Review of Web Servers and Bioinformatics Tools for Cancer Prognosis Analysis
por: Zheng, Hong, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
por: Zhu, Yuanyuan, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer
por: Kong, Xiaoxiao, et al.
Publicado: (2020)

Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
por: Li, Xiao-Yu, et al.
Publicado: (2022)

Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
por: Fan, Yeye, et al.
Publicado: (2022)

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
por: Chen, Xiongfeng, et al.
Publicado: (2022)

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
por: Zhao, Huishan, et al.
Publicado: (2019)

Structural and biochemical studies of the distinct activity profiles of Rai1 enzymes
por: Wang, Vivien Ya-Fan, et al.
Publicado: (2015)

A Comprehensive Model for Diagnosis of Primary Breast Lymphoma Differentiated From Breast Cancer and Prognosis Evaluation of Surgical Treatment
por: Li, Yanan, et al.
Publicado: (2022)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

Effect of Pyroptosis-Related Genes on the Prognosis of Breast Cancer
por: Zhou, Ying, et al.
Publicado: (2022)

Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells
por: Gu, Ming, et al.
Publicado: (2019)

ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer
por: Li, Yilun, et al.
Publicado: (2022)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Rais[z]al /
por: Gómez Palacio y Gutiérrez Zamora, Ignacio
Publicado: (1990)

A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer
por: Wang, Huxia, et al.
Publicado: (2022)

Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer
por: Li, Jieling, et al.
Publicado: (2021)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma
por: Liu, Zhixin, et al.
Publicado: (2023)

High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
por: Cui, Ranliang, et al.
Publicado: (2022)

Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers
por: Zhang, Ling, et al.
Publicado: (2021)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer
por: Diao, Bowen, et al.
Publicado: (2021)

HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
por: Schlosser, Sophie, et al.
Publicado: (2022)

A comprehensive overview of exosome lncRNAs: Emerging biomarkers and potential therapeutics in gynecological cancers
por: Wang, Min, et al.
Publicado: (2023)

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
por: Cai, Qun, et al.
Publicado: (2022)

Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies
por: Lv, Hui, et al.
Publicado: (2020)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vsiooccg9ob9q9oqf7jmfp6euo